Giorgio Mustacchi

1.6k total citations
64 papers, 1.0k citations indexed

About

Giorgio Mustacchi is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Giorgio Mustacchi has authored 64 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 33 papers in Cancer Research and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Giorgio Mustacchi's work include Breast Cancer Treatment Studies (30 papers), Cancer Treatment and Pharmacology (29 papers) and Estrogen and related hormone effects (15 papers). Giorgio Mustacchi is often cited by papers focused on Breast Cancer Treatment Studies (30 papers), Cancer Treatment and Pharmacology (29 papers) and Estrogen and related hormone effects (15 papers). Giorgio Mustacchi collaborates with scholars based in Italy, Spain and France. Giorgio Mustacchi's co-authors include Michelino De Laurentiis, A. De Matteis, Stefano Milani, A. Farris, Alfonso M. Pluchinotta, P. Pronzato, Rita Ceccherini, Marina Elena Cazzaniga, A. Scanni and A. Rubagotti and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Giorgio Mustacchi

63 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giorgio Mustacchi Italy 16 662 587 221 219 206 64 1.0k
K.I. Pritchard Canada 15 682 1.0× 580 1.0× 184 0.8× 183 0.8× 182 0.9× 35 1.1k
Fernando Lara-Medina Mexico 17 487 0.7× 411 0.7× 198 0.9× 159 0.7× 201 1.0× 40 906
Jean-Luc Canon Belgium 16 740 1.1× 473 0.8× 216 1.0× 97 0.4× 209 1.0× 35 1.1k
A. Goldhirsch Italy 15 537 0.8× 382 0.7× 143 0.6× 115 0.5× 135 0.7× 39 825
Karsten E. Weber Germany 16 564 0.9× 801 1.4× 222 1.0× 184 0.8× 379 1.8× 44 1.2k
Roberta Maltoni Italy 21 722 1.1× 376 0.6× 299 1.4× 129 0.6× 338 1.6× 84 1.2k
R. Theriault United States 13 970 1.5× 439 0.7× 162 0.7× 101 0.5× 264 1.3× 25 1.3k
Corinne Veyret France 19 704 1.1× 500 0.9× 391 1.8× 118 0.5× 203 1.0× 62 1.1k
Chantal Bernard-Marty Belgium 14 845 1.3× 441 0.8× 247 1.1× 81 0.4× 280 1.4× 22 1.2k
Marzena Wełnicka-Jaśkiewicz Poland 17 610 0.9× 354 0.6× 154 0.7× 76 0.3× 165 0.8× 42 820

Countries citing papers authored by Giorgio Mustacchi

Since Specialization
Citations

This map shows the geographic impact of Giorgio Mustacchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giorgio Mustacchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giorgio Mustacchi more than expected).

Fields of papers citing papers by Giorgio Mustacchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giorgio Mustacchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giorgio Mustacchi. The network helps show where Giorgio Mustacchi may publish in the future.

Co-authorship network of co-authors of Giorgio Mustacchi

This figure shows the co-authorship network connecting the top 25 collaborators of Giorgio Mustacchi. A scholar is included among the top collaborators of Giorgio Mustacchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giorgio Mustacchi. Giorgio Mustacchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Corona, Silvia Paola, Navid Sobhani, Giandomenico Roviello, et al.. (2017). Advances in systemic therapy for metastatic breast cancer: future perspectives. Medical Oncology. 34(7). 119–119. 31 indexed citations
3.
Cazzaniga, Marina Elena, Giorgio Mustacchi, Emanuela Romagnoli, et al.. (2017). Choice of treatment and adherence to international ESO-ESMO (ABC) guidelines in HR+/HER2-ve metastatic breast cancer (MBC) patients (pts).. Journal of Clinical Oncology. 35(15_suppl). 1057–1057. 1 indexed citations
4.
Mustacchi, Giorgio, Fabio Puglisi, Diana Crivellari, et al.. (2015). Observational Study on Adjuvant Trastuzumab in HER2-Positive Early Breast Cancer Patients. Future Oncology. 11(10). 1493–1500. 9 indexed citations
5.
6.
Mustacchi, Giorgio, Laura Biganzoli, P. Pronzato, et al.. (2015). HER2-positive metastatic breast cancer: A changing scenario. Critical Reviews in Oncology/Hematology. 95(1). 78–87. 24 indexed citations
7.
8.
Campiglio, Manuela, Rosaria Bufalino, Elisa Ferri, et al.. (2013). Effect of adjuvant trastuzumab treatment in conventional clinical setting: an observational retrospective multicenter Italian study. Breast Cancer Research and Treatment. 141(1). 101–110. 20 indexed citations
9.
Arpino, Grazia, Daniele Generali, Anna Sapino, et al.. (2013). Gene expression profiling in breast cancer: A clinical perspective. The Breast. 22(2). 109–120. 57 indexed citations
10.
Mustacchi, Giorgio, et al.. (2012). 5-HTTLPR polymorphism and anxious preoccupation in early breast cancer patients. Radiology and Oncology. 46(4). 321–7. 14 indexed citations
11.
Mustacchi, Giorgio, Annamaria Molino, Elena Fiorio, et al.. (2012). Relapse rate after adjuvant trastuzumab in the northeast of Italy: Preliminary data from a multicenter observational study in a clinical setting.. Journal of Clinical Oncology. 30(15_suppl). 586–586. 2 indexed citations
12.
Clavarezza, Matteo, Giorgio Mustacchi, Andrea Casadei‐Gardini, et al.. (2012). Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study. BMC Cancer. 12(1). 216–216. 6 indexed citations
13.
Mustacchi, Giorgio, Mauro Mansutti, Chiara Sacco, et al.. (2009). Neo-adjuvant exemestane in elderly patients with breast cancer: a phase II, multicentre, open-label, Italian study. Annals of Oncology. 20(4). 655–659. 15 indexed citations
14.
Cazzaniga, Marina Elena, Giorgio Mustacchi, P. Pronzato, et al.. (2007). Adjuvant treatment of early breast cancer: do the St Gallen recommendations influence clinical practice? Results from the NORA study. Annals of Oncology. 18(12). 1976–1980. 7 indexed citations
15.
16.
Mustacchi, Giorgio, et al.. (2002). A phase II study of cisplatin and vinorelbine in patients with metastatic breast cancer. Annals of Oncology. 13(11). 1730–1736. 20 indexed citations
17.
Mustacchi, Giorgio, et al.. (1998). Tamoxifen versus surgery plus Tamoxifen as primary treatment for elderly patients with breast cancer: combined data from the “GRETA” and “CRC” trials. ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/). 17. 10 indexed citations
18.
Boccardo, Francesco, A. Rubagotti, D. Amoroso, et al.. (1998). Italian Breast Cancer Adjuvant Chemo-hormone Therapy Cooperative Group Trials. Recent results in cancer research. 152. 453–470. 6 indexed citations
19.
Boccardo, Francesco, D. Amoroso, A. Rubagotti, et al.. (1993). Endocrine Therapy of Breast Cancer. Annals of the New York Academy of Sciences. 698(1). 318–328. 7 indexed citations
20.
Magini, Angela, Mario Pazzagli, R. Salerno, et al.. (1990). Ovarian function in premenopausal women affected by breast cancer: The measurement of glucuronoconjugate metabolites of 17β-estradiol and progesterone throughout one entire menstrual cycle. Journal of Steroid Biochemistry. 36(6). 523–526. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K.I. Pritchard Breakdown of academic impact, for papers by Fernando Lara-Medina Breakdown of academic impact, for papers by Jean-Luc Canon Breakdown of academic impact, for papers by A. Goldhirsch Breakdown of academic impact, for papers by Karsten E. Weber Breakdown of academic impact, for papers by Roberta Maltoni Breakdown of academic impact, for papers by R. Theriault Breakdown of academic impact, for papers by Corinne Veyret Breakdown of academic impact, for papers by Chantal Bernard-Marty Breakdown of academic impact, for papers by Marzena Wełnicka-Jaśkiewicz
Rankless by CCL
2026